Description
Immune Biosolutions inc. will develop a medical counter measure (MCM) and contribute to Canada's ability to secure an effective therapeutic in response to COVID-19.
Amendment chain · 3 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $13,442,000 at start, $13,442,000 after amendment #2 (+$0).
- #02020-04-29$13,442,000
- #12022-07-06$13,442,000
- #22023-03-28$13,442,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2020-04-29(start date) | $13,442,000 | — | Immune Biosolutions inc. will develop a medical counter measure (MCM) and contribute to Canada's ability to se… |
| #1 amendment | 2022-07-06 | $13,442,000 | +$0 | Immune Biosolutions inc. will develop a medical counter measure (MCM) and contribute to Canada's ability to se… |
| #2 amendment | 2023-03-28 | $13,442,000 | +$0 | Immune Biosolutions inc. will develop a medical counter measure (MCM) and contribute to Canada's ability to se… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 805852886)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2025-2026-Q1-1029947 | National Research Council Canada | Conseil national de recherches Canada · CanExport SME | $13,000 | FY2026 |
| 172-2024-2025-Q3-1024406 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $74,900 | FY2025 |
| 172-2023-2024-Q3-1013458 | National Research Council Canada | Conseil national de recherches Canada · CanExport SME | $27,500 | FY2024 |
| 172-2022-2023-Q2-993841 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $490,750 | FY2023 |
| 172-2021-2022-Q4-984090 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $29,880 | FY2022 |
| 093-2021-2022-Q1-00129 | Canada Economic Development for Quebec Regions | Développement économique Canada pour les régions du Québec · Regional Relief and Recovery Fund (REGI-RRRF) | $372,000 | FY2022 |
Other recipients funded under "SIF Stream 1- R&D" by Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 033-2024-2025-Q2-819558 | Coveo Solutions Inc. | FY2025 | $15,170,000 | FY2025 |
| 033-2024-2025-Q2-816194 | Kepler Communications Inc. | FY2025 | $20,000,000 | FY2025 |
| 033-2024-2025-Q2-819803 | Pratt & Whitney Canada Corporation | FY2025 | $11,322,000 | FY2025 |
| 033-2024-2025-Q1-820045 | Biotechnologies Aramis Inc. | FY2025 | $40,000,000 | FY2025 |
| 033-2023-2024-Q3-514239 | Edesa Biotech Research, Inc. | FY2024 | $23,000,000 | FY2024 |
Cite as: Glassbox record view · Federal grants & contributions · 033-2020-2021-Q4-513419 · retrieved 2026-11-15.